In the largest, most contemporary Mendelian randomization analysis for metabolic traits and breast cancer survival outcomes, we identified associations between PGS for CVD, cystatin C levels, and hypertension in relation to breast cancer survival outcomes at a nominal statistical significance level. This evidence concerns the gene CST3 and breast cancer.